Aprotinin administration in the pericardial cavity does not prevent platelet activation.
Landis
R C
RC
Taylor
K M
KM
D007611:Aprotinin / Q000008:administration & dosage / Q000494:pharmacology*; D002315:Cardiopulmonary Bypass; D006490:Hemostatics / Q000008:administration & dosage / Q000494:pharmacology*; D006801:Humans; D010496:Pericardium; D015539:Platelet Activation / Q000187:drug effects*
D006490:Hemostatics; D007611:Aprotinin